Juul e-cigarette: Clinical Trials

5 trials of Juul e-cigarette, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 unknown. 4 Phase 2, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4
Not applicable1Unknown 1

Follow Juul e-cigarette: new trials by email Literature Review of Juul e-cigarette trials Research Report on Juul e-cigarette

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Assisting Smokers to Switch to an e-Cigarette by Accelerating Learning of Adaptive Habits Using D-cycloserine
d-cycloserine, Juul e-cigarette - Smoking Cessation, Harm Reduction
Phase 2CompletedRose Research Center, LLC252023-10-202026-01-20
Cigarette Consumption After switchinG to High or Low Nicotine strENght E-cigaretteS In Smokers With Schizophrenia
JUUL E-CIGARETTE - Smoking, Schizophrenia Spectrum and Other Psychotic Disorders
Not applicableUnknownUniversity of Catania2602021-10-302024-05-08
Do Flavors Increase the Addiction Potential of Nicotine?
Nicotine, JUUL e-cigarette - Nicotine Dependence
Phase 2CompletedUniversity of Vermont192021-03-012022-03-22
E-cigarette Nicotine Study
Nicotine, Juul e-cigarette, Reduction - Nicotine Dependence, Electronic Cigarette Use
Phase 2CompletedUniversity of Vermont772021-01-202022-08-26
Abuse Liability of Reduced Nicotine Content Cigarettes in the Context of Concurrent E-Cigarette Use
Smoking research cigarettes with e-cigarette, Nicotine discrimination thresholds - Nicotine Addiction, Cigarette Smoking
Phase 2CompletedRose Research Center, LLC1502019-05-012022-01-14

Conditions studied

Tobacco Use Disorder (3)  ·  Cigarette Smoking (2)  ·  Harm Reduction (1)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (1)  ·  Smoking (1)  ·  Smoking Cessation (1)  ·  Vaping (1)

Sponsors

Rose Research Center, LLC (2)  ·  University of Vermont (2)  ·  University of Catania (1)

Countries

United States (4)  ·  Italy (1)

Top investigators

Jed E Rose, Ph.D. (1)  ·  John R Hughes, MD (1)  ·  Pasquale Caponnetto (1)

Results publications

PMID 36048114

NIH funding

R01DA042541 (1)